According to IQVIA, selexipag tablets have an estimated market size of $461 million for twelve months ending September 2021. Alembic has now received year to date 15 approvals (11 final approvals and 4 tentative approvals) and a cumulative total of 154 ANDA 'approvals (134 final approvals arid 20 tentative approvals) from USFDA.

Alembic Pharmaceuticals is a vertically integrated research and development pharmaceutical company. It manufactures and markets generic pharmaceutical products all over the world.

The drug maker's consolidated net profit dropped 49.22% to Rs 169.29 crore on a 11.31% fall in sales to Rs 1,292.32 crore in Q2 FY22 over Q2 FY21.